Phibro Animal Health CorpNASDAQ:PAHC
- LAST PRICE21.9900
- TODAY'S CHANGE (%)-0.2900 (-1.3016%)
- Bid / Lots19.8200/ 1
- Ask / Lots22.0000/ 1
- Open / Previous Close22.1000 / 22.2800
- Day Range
- 52 Week Range
- Volume193,905
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | PAHC |
|---|---|---|
| 09:32 ET | 4781 | 22.04 |
| 09:34 ET | 131 | 22.03 |
| 09:36 ET | 160 | 22.055 |
| 09:38 ET | 675 | 22.05 |
| 09:45 ET | 1670 | 21.8619 |
| 09:48 ET | 1050 | 21.86 |
| 09:52 ET | 300 | 21.85 |
| 09:59 ET | 100 | 21.86 |
| 10:03 ET | 976 | 21.85 |
| 10:06 ET | 1036 | 21.92 |
| 10:08 ET | 3009 | 21.87 |
| 10:12 ET | 200 | 21.86 |
| 10:14 ET | 1293 | 21.8 |
| 10:15 ET | 237 | 21.86 |
| 10:17 ET | 700 | 21.86 |
| 10:19 ET | 400 | 21.86 |
| 10:21 ET | 200 | 21.84 |
| 10:26 ET | 1400 | 22.04 |
| 10:30 ET | 3535 | 21.99 |
| 10:32 ET | 200 | 21.98 |
| 10:33 ET | 200 | 21.98 |
| 10:35 ET | 200 | 21.98 |
| 10:37 ET | 400 | 21.975 |
| 10:39 ET | 4013 | 21.93 |
| 10:42 ET | 100 | 21.95 |
| 10:44 ET | 850 | 21.95 |
| 10:48 ET | 100 | 21.98 |
| 10:50 ET | 1500 | 21.95 |
| 10:51 ET | 684 | 21.8 |
| 10:53 ET | 2750 | 21.795 |
| 10:55 ET | 500 | 21.8 |
| 10:57 ET | 1200 | 21.75 |
| 11:00 ET | 600 | 21.79 |
| 11:02 ET | 200 | 21.79 |
| 11:04 ET | 700 | 21.715 |
| 11:06 ET | 450 | 21.625 |
| 11:15 ET | 361 | 21.72 |
| 11:26 ET | 203 | 21.7292 |
| 11:31 ET | 3456 | 21.7 |
| 11:36 ET | 200 | 21.68 |
| 11:44 ET | 335 | 21.615 |
| 11:45 ET | 100 | 21.615 |
| 11:58 ET | 100 | 21.62 |
| 12:00 ET | 200 | 21.6733 |
| 12:02 ET | 113 | 21.6777 |
| 12:05 ET | 1256 | 21.55 |
| 12:14 ET | 2395 | 21.7 |
| 12:16 ET | 994 | 21.7 |
| 12:18 ET | 2496 | 21.7 |
| 12:20 ET | 300 | 21.7 |
| 12:21 ET | 100 | 21.7 |
| 12:25 ET | 832 | 21.735 |
| 12:27 ET | 600 | 21.735 |
| 12:30 ET | 100 | 21.735 |
| 12:32 ET | 414 | 21.735 |
| 12:34 ET | 300 | 21.735 |
| 12:36 ET | 400 | 21.735 |
| 12:38 ET | 12695 | 21.74 |
| 12:39 ET | 2899 | 21.85 |
| 12:41 ET | 100 | 21.88 |
| 12:43 ET | 267 | 21.85 |
| 12:45 ET | 650 | 21.8 |
| 12:48 ET | 100 | 21.79 |
| 12:52 ET | 1567 | 21.8 |
| 12:54 ET | 1030 | 21.8 |
| 12:56 ET | 4515 | 21.8 |
| 12:57 ET | 865 | 21.8 |
| 12:59 ET | 370 | 21.8 |
| 01:01 ET | 4097 | 21.83 |
| 01:03 ET | 100 | 21.81 |
| 01:06 ET | 1406 | 21.8 |
| 01:08 ET | 756 | 21.8 |
| 01:15 ET | 2172 | 21.8 |
| 01:17 ET | 100 | 21.79 |
| 01:24 ET | 100 | 21.79 |
| 01:26 ET | 2100 | 21.8 |
| 01:28 ET | 300 | 21.78 |
| 01:30 ET | 2529 | 21.8 |
| 01:32 ET | 850 | 21.8 |
| 01:35 ET | 5426 | 21.8 |
| 01:37 ET | 1650 | 21.8 |
| 01:39 ET | 950 | 21.8 |
| 01:42 ET | 1400 | 21.89 |
| 01:50 ET | 700 | 21.845 |
| 01:55 ET | 200 | 21.84 |
| 01:57 ET | 300 | 21.825 |
| 02:00 ET | 400 | 21.87 |
| 02:08 ET | 200 | 21.88 |
| 02:20 ET | 200 | 21.92 |
| 02:38 ET | 1650 | 21.9 |
| 02:45 ET | 600 | 22.005 |
| 02:49 ET | 600 | 21.97 |
| 02:56 ET | 400 | 21.91 |
| 03:02 ET | 100 | 21.931 |
| 03:07 ET | 1500 | 21.95 |
| 03:09 ET | 100 | 21.93 |
| 03:12 ET | 100 | 21.925 |
| 03:18 ET | 100 | 21.955 |
| 03:25 ET | 2300 | 21.945 |
| 03:30 ET | 658 | 21.89 |
| 03:32 ET | 100 | 21.94 |
| 03:34 ET | 100 | 21.94 |
| 03:36 ET | 100 | 21.97 |
| 03:38 ET | 514 | 21.91 |
| 03:39 ET | 100 | 21.9 |
| 03:45 ET | 200 | 21.91 |
| 03:48 ET | 400 | 21.91 |
| 03:50 ET | 100 | 21.92 |
| 03:52 ET | 100 | 21.925 |
| 03:54 ET | 300 | 21.915 |
| 03:56 ET | 1343 | 21.91 |
| 03:57 ET | 2285 | 21.95 |
| 03:59 ET | 27833 | 21.99 |
Sep 10, 2024
DJ Phibro Animal Health Initiated at Neutral by JP Morgan, from 8:44AM ET on Tuesday Sep 10, 2024 by Dow Jones
8:44AM ET on Tuesday Sep 10, 2024 by Dow Jones
Aug 30, 2024
DJ Phibro Animal Health Is Maintained at Underperform by B of A Securities, from 8:15AM ET on Friday Aug 30, 2024 by Dow Jones
8:15AM ET on Friday Aug 30, 2024 by Dow Jones
Aug 29, 2024
Phibro Animal Health Corporation to Participate at Morgan Stanley Annual Global Healthcare Conference, from 4:00PM ET on Thursday Aug 29, 2024 by Dow Jones
4:00PM ET on Thursday Aug 29, 2024 by Dow Jones
Aug 28, 2024
Press Release: Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial Guidance, from 4:53PM ET on Wednesday Aug 28, 2024 by Dow Jones
4:53PM ET on Wednesday Aug 28, 2024 by Dow JonesPhibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial Guidance, from 4:53PM ET on Wednesday Aug 28, 2024 by Dow Jones
4:53PM ET on Wednesday Aug 28, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Phibro Animal Health Corp | 902.4M | 369.3x | -46.35% |
PetIQ Inc | 926.3M | 81.0x | --- |
Supernus Pharmaceuticals Inc | 1.8B | 355.7x | -59.02% |
Eagle Pharmaceuticals Inc | 51.4M | 4.3x | -4.75% |
Shengtai Pharmaceutical Inc | 10.0 | 0.0x | --- |
Medicine Man Technologies Inc | 7.3M | --- | --- |
Company Information
Phibro Animal Health Corporation is a global diversified animal health and mineral nutrition company. It develops, manufactures and markets a range of products for food and companion animals, including poultry, swine, beef and dairy cattle, aquaculture and dogs. It markets approximately 750 product lines in over 80 countries to approximately 4,200 customers. It has three segments: Animal Health, Mineral Nutrition and Performance Products. Its Animal Health segment develops, manufactures and markets about 280 product lines, including antibacterials, anticoccidials and related products; nutritional specialty products; and vaccines. The Mineral Nutrition segment is comprised of formulations and concentrations of trace minerals such as zinc, manganese, copper, iron and other compounds, with a focus on customers in North America. The Performance Products segment manufactures and markets specialty ingredients for use in the personal care, industrial chemical and chemical catalyst industries.
Contact Information
- Headquarters
- 300 Frank W. Burr Blvd. Suite 21, 65 Challenger RoadTEANECK, NJ, United States 07666
- Phone
- 201-329-7300
- Fax
- 302-655-5049
Executives
- Chairman of the Board, President, Chief Executive Officer
- Jack Bendheim
- Chief Financial Officer
- Glenn David
- Director, President of MACIE Region and General Manager of Israel Operations
- Jonathan Bendheim
- President, North America Region
- Rob Aukerman
- Chief Operating Officer
- Larry Miller
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $902.4M |
|---|---|
Revenue (TTM) | $1.0B |
Shares Outstanding | 40.5M |
Dividend Yield | 2.18% |
Annual Dividend Rate | 0.4800 USD |
Ex-Dividend Date | 09-04-24 |
Pay Date | 09-25-24 |
Beta | 0.52 |
EPS | $0.06 |
Book Value | $6.34 |
P/E Ratio | 369.3x |
Price/Sales (TTM) | 0.9 |
Price/Cash Flow (TTM) | 23.4x |
Operating Margin | 5.24% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
